CA2095925A1 - Erythrocytes and thrombo-erythrocytes as target specific abents - Google Patents
Erythrocytes and thrombo-erythrocytes as target specific abentsInfo
- Publication number
- CA2095925A1 CA2095925A1 CA002095925A CA2095925A CA2095925A1 CA 2095925 A1 CA2095925 A1 CA 2095925A1 CA 002095925 A CA002095925 A CA 002095925A CA 2095925 A CA2095925 A CA 2095925A CA 2095925 A1 CA2095925 A1 CA 2095925A1
- Authority
- CA
- Canada
- Prior art keywords
- erythrocyte
- thrombo
- erythrocytes
- molecule
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61116490A | 1990-11-09 | 1990-11-09 | |
US611,164 | 1990-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2095925A1 true CA2095925A1 (en) | 1992-05-10 |
Family
ID=24447889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002095925A Abandoned CA2095925A1 (en) | 1990-11-09 | 1991-11-12 | Erythrocytes and thrombo-erythrocytes as target specific abents |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0558645A4 (fi) |
JP (1) | JPH06504535A (fi) |
KR (1) | KR930702341A (fi) |
AU (1) | AU651643B2 (fi) |
CA (1) | CA2095925A1 (fi) |
FI (1) | FI932114A (fi) |
WO (1) | WO1992008804A1 (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6017877A (en) * | 1990-04-06 | 2000-01-25 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
GB9705787D0 (en) | 1997-03-20 | 1997-05-07 | Thrombosis Res Inst | Modified dendroaspins |
CA2317640A1 (en) * | 1998-01-06 | 1999-07-15 | Trustees Of Boston University | Decorated red blood cells |
DE10038900A1 (de) * | 2000-08-09 | 2002-03-07 | Haemosys Gmbh | Einfache Methode zum drug monitoring von GPIIb/IIIa-Rezeptor-Antagonisten |
US7195919B2 (en) * | 2003-12-19 | 2007-03-27 | Beckman Coulter, Inc. | Hematology controls for reticulocytes and nucleated red blood cells |
DE102004054536A1 (de) * | 2004-11-06 | 2006-05-11 | Capsulution Nanoscience Ag | Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel |
CN102294016B (zh) * | 2006-01-19 | 2014-05-21 | 爱吉恩公司 | 治疗血管相关疾病的包含肽的药物组合物 |
EP1849482A1 (en) * | 2006-04-25 | 2007-10-31 | Capsulution Nanoscience AG | Multimodally altered cells as a form for administering active substances and as diagnostic particles |
KR100824396B1 (ko) | 2006-10-10 | 2008-04-22 | (주)케어젠 | 상피세포 성장인자의 활성을 가지는 펩타이드 및 그의 용도 |
CN101625267B (zh) * | 2008-07-11 | 2011-07-20 | 财团法人工业技术研究院 | 热侦测系统及其侦测方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377567A (en) * | 1978-10-02 | 1983-03-22 | The Procter & Gamble Company | Lipid membrane drug delivery |
DE3218121A1 (de) * | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
US4792525A (en) * | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4988621A (en) * | 1985-05-24 | 1991-01-29 | La Jolla Cancer Research Foundation | Peptides in cell detachment and aggregation |
JPS62190129A (ja) * | 1986-02-18 | 1987-08-20 | Green Cross Corp:The | 制癌剤含有マイクロキヤリアの製造方法 |
US5000960A (en) * | 1987-03-13 | 1991-03-19 | Micro-Pak, Inc. | Protein coupling to lipid vesicles |
-
1991
- 1991-11-12 EP EP19920901253 patent/EP0558645A4/en not_active Withdrawn
- 1991-11-12 KR KR1019930701399A patent/KR930702341A/ko not_active Application Discontinuation
- 1991-11-12 CA CA002095925A patent/CA2095925A1/en not_active Abandoned
- 1991-11-12 AU AU90588/91A patent/AU651643B2/en not_active Ceased
- 1991-11-12 WO PCT/US1991/008430 patent/WO1992008804A1/en not_active Application Discontinuation
- 1991-11-12 JP JP4502274A patent/JPH06504535A/ja active Pending
-
1993
- 1993-05-10 FI FI932114A patent/FI932114A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI932114A (fi) | 1993-07-01 |
AU9058891A (en) | 1992-06-11 |
KR930702341A (ko) | 1993-09-08 |
WO1992008804A1 (en) | 1992-05-29 |
JPH06504535A (ja) | 1994-05-26 |
AU651643B2 (en) | 1994-07-28 |
EP0558645A1 (en) | 1993-09-08 |
FI932114A0 (fi) | 1993-05-10 |
EP0558645A4 (en) | 1994-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5328840A (en) | Method for preparing targeted carrier erythrocytes | |
Vogt et al. | Interaction of cationized antigen with rat glomerular basement membrane: In situ immune complex formation | |
Coller et al. | Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. | |
JP3926839B2 (ja) | 万能dr−結合性ペプチドを用いる免疫応答の改変 | |
US5110730A (en) | Human tissue factor related DNA segments | |
CA2000048A1 (en) | Peptides and antibodies that inhibit integrin-ligand bindin g | |
AU651643B2 (en) | Erythrocytes and thrombo-erythrocytes as target specific agents | |
JP2846470B2 (ja) | Hlaペプチドによるリンパ球活性の調節 | |
US5620956A (en) | Methods of using CD8 binding domain peptides | |
JPH05501400A (ja) | アポリポタンパクeのポリペプチド類似体、診断系および該類似体の使用法 | |
CA1339185C (en) | Lymphocyte inhibition by hla peptides | |
CA2541005C (en) | Fibrinogen targetting microparticles for promoting haemostasis | |
Wholey et al. | Synthetic liposomal mimics of biological viruses for the study of immune responses to infection and vaccination | |
AU676483B2 (en) | Polypeptides, derived from endonexin 2, having hepatitis B virus receptor activity and their use in diagnostic and pharmaceutical compositions | |
JPH10511954A (ja) | 抗炎症cd14ペプチド | |
JP2001511762A (ja) | 選択性スロンビン抑制剤としてのブラジキニン同族体 | |
Fu et al. | Immunocytochemical localization of M2 muscarinic receptors in rat ventricles with anti-peptide antibodies. | |
EP0333517A2 (en) | Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor | |
WO1993016712A1 (en) | MUTANT GPIbα FRAGMENTS AND RECOMBINANT EXPRESSION THEREOF | |
WO1996011700A1 (en) | Reduction of mammalian neoplasms with phospholipase a2 activatiing substances | |
MXPA01004949A (es) | Uso de particulas de capside de parvovirus en la inhibicion de la proliferacion y la migracion celular. | |
JPH08511941A (ja) | ヒト細胞接着性タンパク質aamp‐1及びその利用 | |
WO1998017242A1 (en) | Unique peptides for targeting fibronectin-enriched surfaces and a method for their delivery in the treatment of metastatic cancer | |
CA2324864A1 (en) | Immune response modulator alpha-2 macroglobulin complex | |
CA2392387A1 (en) | Polypeptides and methods for thymic vaccination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19960512 |